is tirzepatide good for high blood pressure Potential mechanisms by which imparts cardiovascular Tirzepatide Injections for Medical Weight

Medical Disclaimer: The content, text, graphics, and data offered herein are provided solely to educate readers on health care and medical issues

SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy

Unlike traditional weight-loss medications that target only one metabolic pathway, Tirzepatide activates two key hormone receptors (GIP & GLP-1)

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Finan B, Ma T, Ottaway N, Muller TD, Habegger KM, Heppner KM, et al